Dr. Eric Golding

Biography

Eric M. Golding is a Lecturer at the Yale School of Management, specializing in management with a keen focus on healthcare and life sciences investment. He currently manages a healthcare and life sciences portfolio for a large family office, leveraging his extensive experience in private and public markets. Golding has previously worked at Consonance Capital, a healthcare-only long/short public equity fund that specializes in biopharmaceuticals and medical devices. Before his tenure at Consonance, he was involved in venture capital at F-Prime Capital Partners, a global venture capital firm known for its focus on biotechnology and pharmaceuticals. At F-Prime, he served as a Board Observer for Iora Health, which emphasizes IT-enabled healthcare services, and Symbiomix Therapeutics, a women's health therapeutics company. He completed his medical training in Internal Medicine at Beth Israel Deaconess Medical Center, a Harvard Medical School affiliate, and has gained insights into pharmaceutical regulation through an internship at the FDA. Golding holds an MD from the Yale School of Medicine and an MBA from the Yale School of Management, alongside a summa cum laude BA from the University of Pennsylvania.

Research Interests

Courses